Search
for
Sort by
Research 121–150 of 1000+
- Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Janus kinase inhibitors for alopecia areata: A narrative review
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Ritlecitinib: First Approval
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- MIM and Cortactin Antagonism Regulates Ciliogenesis and Hedgehog Signaling
- Protein Kinase Cε, which Sensitizes Skin to Sun's UV Radiation–Induced Cutaneous Damage and Development of Squamous Cell Carcinomas, Associates with Stat3
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Hair Follicle Reconstruction and Stem Cells
- Modern Management Approaches for Alopecia Areata
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Protein Kinase C as a Therapeutic Target
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Protein Kinase C δ Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation–Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches